Joyce Massey Summit III Logo.png
 

The Future of TBI Research

The 2019 Joyce Massey TBI Summit brings together leading scientists and key opinion leaders to present cutting-edge research, exchange ideas, and discuss the future of TBI research. 

We encourage investigators from all disciplines and career levels to join us to learn about current research barriers, and the future direction of research.


Keynote Speakers

David Menon.png

Head, Division of Anaesthesia
University of Cambridge

Dave Woodruff.png

Co-Founder & Chairman, Bob Woodruff Foundation

Midwest Director of Sales & Marketing, Entrepreneur Media

 
Navy Block.png

Venues

Welcome Dinner (Invite Only)
Thursday, October 17 | 6 PM | Matthaei Botanical Gardens

UM-Golf_3-758x407.jpg

Summit

Friday, October 18 | 8 AM | Richard L. Postma Family Clubhouse

Navy Block.png

Featured Mentors

Geoffrey Manley, MD, PhD

University of California San Francisco & San Francisco General Hospital

Harvey Levin, PhD

Baylor College of Medicine

Jed A. Hartings, PhD

University of Cincinnati

David Okonkwo, MD, PhD

University of Pittsburgh

Ramon Diaz-Arrastia, MD, PhD

Penn Medicine

C. Edward Dixon, PhD

University of Pittsburgh

Pratik Mukherjee, MD, PhD

University of California San Francisco

Edward D. Hall, PhD

University of Kentucky

Joseph Giacino, PhD

Spaulding Rehabilitation Hospital

Navy Block.png

Summit Schedule

8:00 AM – 8:25 AM – Registration

8:30 AM – Welcome Remarks & Acknowledgement of The Joyce Massey Foundation
Dr. Neumar, Chair and Professor of Emergency Medicine, University of Michigan

8:45 AM - Keynote Speaker #1
Dr. David Menon, Head, Division of Anaesthesia, University of Cambridge

9:35 AM - BREAK

9:50 AM – Mentee Talks
John Burke, MD, PhD
- “The incidence and risk factors of post-traumatic epilepsy after TBI”
Jeffrey Brennan - “The Diagnostic Utility and Biomarker Relationships of LOC: Exploratory Findings from TRACK-TBI”
Brandon Foreman, MD, FACNS, FNCS - “Precision Physiology in the ICU: A Big Data Problem”
Jacob R. Joseph, MD - “p-tau as a Prognostic Biomarker Following Severe Traumatic Brain Injury”
Ramani Balu, MD, PhD - “Continuous non-invasive optical monitoring of cerebral blood flow and oxidative metabolism after acute brain injury”
Shaun Carlson, PhD - “Synaptic changes after repeated fluid percussion injury as a rat model of repeated injury”
Jacob A. Dunkerson - “Towards a Novel Neuroprotective Approach for Taumatic Brain Injury: Harnessing the Nrf2 – Antioxidant Response Element”
Brian L. Edlow, MD - “Mapping the Connectivity of Consciousness”

12:00 PM - Lunch/Poster Session/Group Photo

1:00 PM - Keynote Speaker #2 - Fireside Chat
Dave Woodruff, Co-Founder & Chairman, Bob Woodruff Foundation; Midwest Director of Sales & Marketing, Entrepreneur Media
Emcee: Dr. Kevin Ward, Professor, Emergency Medicine, University of Michigan; Executive Director, MCIRCC

1:45 PM – BREAK

2:00 PM – Key Opinion Leader Session 
Geoffrey T. Manley, MD, PhD
- “TRACK-TBI: Early Deliverables and Future Directions”
Harvey Levin, PhD - “Lack of understanding the mechanism underpinning the sex difference in recovery from sports related concussion and other causes of mTBI”
Jed A. Hartings, PhD - “We need a medical device that can reliably monitor cortical spreading depolarizations non-invasively”
David Okonkwo, MD, PhD - “Blood-based biomarkers of TBI pathophysiology”
Ramon Diaz-Arrastia, MD, PhD - “Need for non-invasive bedside monitoring of cerebral metabolism/activity/bloodflow/ischemia”
C. Edward Dixon, PhD - “Inadequate clinical translation of preclinical therapeutic findings”
Pratik Mukherjee, MD, PhD - “Developing a Clinically Useful Prognostic Biomarker for Post-Concussion Syndrome”
Edward D. Hall, PhD - “Are the neuroprotective therapeutic windows and needed treatment durations for treating TBI in rodents and humans different?”
Joseph Giacino, PhD - “To move the TBI field forward, we need to be able to identify distinct TBI phenotypes that reflect the anatomic, pathophysiologic and clinical features of the injury. This would enable more precise prognostication and treatment targeting.”

3:00 PM – Group Discussion/Q & A 

3:45 PM - Wrap Up/Next Steps/Adjourn
Dr. Neumar, Chair and Professor of Emergency Medicine, University of Michigan